Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Valero Energy Corporation — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B), while Valero Energy Corporation trades at $461.44 (market cap $131.43B). The key difference: Valero Energy Corporation is far larger — about 14.8× Kymera Therapeutics Inc. Common Stock's market cap, and Valero Energy Corporation pays a 1.05% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Valero Energy Corporation for 57 Days on average.
| KYMR | VLO | |
|---|---|---|
Market Cap | $8.88B | $131.43B |
Volume | 1,028,790 | 2,513,030 |
Sector | Health | Energy |
52-Week High | $127.31 | $459.78 |
52-Week Low | $55.80 | $156.39 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $8.27B | $134.90B |
Dividend Yield | — | 1.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Valero Energy (VLO) trades at $456.46, up 4.69% today and near its 52-week high, with a bullish technical outlook supported by moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 expected at $20.83 EPS. Revenue declined to $122.69B in 2025, but net income margin improved to 5.17%, and strong cash flow supports a $1.20 dividend. Analyst sentiment is positive with 57% buy ratings.
VLO presents a bullish case with robust profitability and growth prospects, but faces risks from volatile refining margins and potential policy impacts like diesel export bans. The stock's valuation at a P/E of 19.04 is reasonable given high ROE of 29.31%, though high RSI levels suggest caution for near-term entry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
